The tumor-associated carbohydrate antigen/hapten Thomsen-nouveau (Tn; α-D-GalpNAc-ONH2) was conjugated to a zwitterionic capsular polysaccharide, PS A1, from commensal anaerobe Bacteroides fragilis ATCC 25285/NCTC 9343 for the development of an entirely carbohydrate cancer vaccine construct and probed for immunogenicity. This communication discloses that murine anti-Tn IgG3 antibodies both bind to and recognize human tumor cells that display the Tn hapten. Furthermore, the sera from immunization of mice with Tn-PS A1 contain cytokine interleukin 17 (IL-17A), which is known to possess anti-tumor function and represents a striking difference to an IL-2, and IL-6 profile obtained with anti-PS A1 sera.
This is a preview of subscription content, log in to check access.
Authors thank Dr. Mary Kay Pflum for Jurkat and JurkatTAg cell lines. P.R.A acknowledges Wayne State University for financial support and the National Institutes of Health/National Cancer Institute for an R01 CA 156661 award.
Conflict of interest
The authors declare that they have no conflict of interest.
Avery OT, Goebel WF (1929) Chemo-immunological studies on conjugated carbohydrate-proteins: II. Immunological specificity of synthetic sugar-protein antigens. J Exp Med 50:533–550PubMedCrossRefGoogle Scholar
Landsteiner K, van der Scheer J (1927) On the influence of acid groups on the serological specificity of azoproteins. J Exp Med 45:1045–1056PubMedCrossRefGoogle Scholar
Astronomo RD, Burton DR (2010) Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat Rev Drug Discov 9:308–324PubMedCrossRefGoogle Scholar
Galonic DP, Gin DY (2007) Chemical glycosylation in the synthesis of glycoconjugate antitumor vaccines. Nature 446:1000–1007PubMedCrossRefGoogle Scholar
Velez CD, Lewis CJ, Kasper DL, Cobb BA (2009) Type I streptococcus pneumonia carbohydrate utilizes a nitric oxide and MHC II-dependent pathway for antigen presentation immunology 127:73–82Google Scholar
Jegerlehner A et al (2010) Carrier induced epitomic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies. Vaccine 28:5503–5512PubMedCrossRefGoogle Scholar
Zijlstra A, Testa JE, Quigley JP (2003) Targeting the proteome/epitome, implementation of subtractive immunization. Biochem Biophys Res Commun 303:733–744PubMedCrossRefGoogle Scholar
Cobb BA, Wang Q, Tzianabos AO, Kasper DL (2004) Polysaccharide processing and presentation by the MHCII pathway. Cell 117:677–687PubMedCrossRefGoogle Scholar
De Silva RA, Wang Q, Chidley T, Appulage DK, Andreana PR (2009) Immunological responses from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates. J Am Chem Soc 131:9622–9623PubMedCrossRefGoogle Scholar
Markham RB, Pier GB, Schreiber JR (1991) The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa. J Immunol 146:316–320PubMedGoogle Scholar
Perlmutter RM, Hansburg D, Briles DE, Nicolotti RA, Davie JM (1978) Subclass restriction of murine anti-carbohydrate antibodies. J Immunol 121:566–572PubMedGoogle Scholar
Azeredo da Silveira S et al (2002) Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody. J Exp Med 195:665–672PubMedCrossRefGoogle Scholar
An Z (2009) Therapeutic monoclonal antibodies: from bench to clinic, Ch 16. Wiley, New JerseyGoogle Scholar
Carcel-Trullols J (2006) Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant. Int J Oncol 28:1173–1183PubMedGoogle Scholar
Fernsten P, Shaw M, Hocker S, Fulghum R, Winfield J (1998) Expression of the sialosyl-Tn epitope on CD45 derived from activated peripheral blood T cells. Immunol Invest 27:323–338PubMedCrossRefGoogle Scholar
Thurnher M, Rusconi S, Berger EG (1993) Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome. J Clin Invest 91:2103–2110PubMedCrossRefGoogle Scholar